Category Archives : News

Home  >>  News

Miltenyi Biotec joins EMBL’s Corporate Partnership Programme

On January 18, 2019, Posted by , In News, By , , With Comments Off on Miltenyi Biotec joins EMBL’s Corporate Partnership Programme

Joining forces to advance training in biomedical research and therapy EMBL and Miltenyi Biotec, a global provider of products and services that advance biomedical research and cellular therapy from basic and translational research to clinical application, have teamed up in the EMBL Advanced Training Centre Corporate Partnership Programme to advance research…

BioMed X and Boehringer Ingelheim to investigate early intervention in psychiatric diseases

On January 18, 2019, Posted by , In News, By , , With Comments Off on BioMed X and Boehringer Ingelheim to investigate early intervention in psychiatric diseases

Heidelberg, Germany, January 17th, 2019 – BioMed X announced a new crowdsourcing project within its framework collaboration with Boehringer Ingelheim. BioMed X and Boehringer Ingelheim started their partnership in 2014 and since then have initiated three preclinical research projects in the fields of respiratory diseases, neuroscience and immunology. The new…

“Life Time” – European research for a healthier future

On January 15, 2019, Posted by , In News, By , , With Comments Off on “Life Time” – European research for a healthier future

Our body’s cells are constantly changing. But which of these changes are healthy developments and which lead to serious diseases? This is what LifeTime, a new transnational and interdisciplinary initiative of leading European researchers, aims to discover. The consortium is jointly coordinated by the Max Delbrück Center in Berlin and…

AbbVie: towards innovative therapies with “Alfons”

On January 15, 2019, Posted by , In News, By , , With Comments Off on AbbVie: towards innovative therapies with “Alfons”

What does the future of research actually look like? Alfons” gives an answer to this question. What sounds like a first name that has gone out of fashion stands for the finest in high technology. “Automated Liquid Formulation Screening” is a real innovation: Using the data generated with this system,…

New member: Welcome in our cluster to Catalent

On January 8, 2019, Posted by , In News, By , With Comments Off on New member: Welcome in our cluster to Catalent

We are happy to welcome in our cluster Catalent: Catalent is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products. With 85 years serving the industry, Catalent has the proven expertise, superior technologies and flexible solutions at the right scale to…

Velabs Therapeutics to Cooperate with BioMed X in the Field of Immunology

On January 7, 2019, Posted by , In News, With Comments Off on Velabs Therapeutics to Cooperate with BioMed X in the Field of Immunology

Velabs Therapeutics, specializing in the fast generation of functional therapeutic antibodies, today announced that it has entered into a collaboration agreement with BioMed X Innovation Center, Heidelberg. The collaboration will capitalize on Velabs’ microfluidics-based technology in the field of T-cell screening.   The BioMed X Innovation Center is a new…

HI-STEM/DKFZ: Human blood cells can be directly reprogrammed into neural stem cells

On December 21, 2018, Posted by , In News, By , , With Comments Off on HI-STEM/DKFZ: Human blood cells can be directly reprogrammed into neural stem cells

Scientists from the German Cancer Research Center (DKFZ) and the stem cell institute HI-STEM* in Heidelberg have succeeded for the first time in directly reprogramming human blood cells into a previously unknown type of neural stem cell. These induced stem cells are similar to those that occur during the early…

HD University Hospital: Nature publication reports first-in-human trial of a novel actively personalized therapeutic vaccine for brain cancer

On December 20, 2018, Posted by , In News, With Comments Off on HD University Hospital: Nature publication reports first-in-human trial of a novel actively personalized therapeutic vaccine for brain cancer

The prospect of an actively personalized approach to the treatment of glioblastoma has moved a step closer with the recent publication in Nature of favorable data from the phase 1 study GAPVAC-101, testing a novel therapeutic concept tailored to specific characteristics of patients’ individual tumors and immune systems. For the…

Europe’s top health start-ups in Biotech, Medtech and Digital Health win cash and recognition at EIT Health Summit

On December 17, 2018, Posted by , In News, By , With Comments Off on Europe’s top health start-ups in Biotech, Medtech and Digital Health win cash and recognition at EIT Health Summit

Finals held for European Health Catapult and Bootcamp pitch contest   SyNoesis, a start-up developing a cure for Parkinson’s Disease, Sleepiz, a contact-free device for home diagnosis of sleep apnea, and Aenitis, whose device improves sorting of cells in suspensions, were top winners in the three categories of the European…

Jan Korbel And Stefan Pfister Receive HMLS Investigator Award

On December 14, 2018, Posted by , In News, With Comments Off on Jan Korbel And Stefan Pfister Receive HMLS Investigator Award

Prize for Heidelberg Molecular Life Sciences endowed with 100,000 euros For their ongoing commitment to promote groundbreaking collaborations in Heidelberg and to establish new methods of research in the molecular life sciences, especially cancer research, Dr Jan Korbel and Prof. Dr Stefan Pfister will share this year’s HMLS Investigator Award….